<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is believed to arise from metaplastic mucosa in the distal oesophagus, a condition also known as <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> (BE) </plain></SENT>
<SENT sid="1" pm="."><plain>BE develops as a result of injury caused by refluxing gastric and duodenal contents and is associated with increased risk of <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Matrix metalloproteinases (MMPs) have been implicated in <z:hpo ids='HP_0000001'>all</z:hpo> aspects of <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumour progression</z:e>; <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e>, basement membrane degradation, invasion and metastatic spread </plain></SENT>
<SENT sid="3" pm="."><plain>Using in situ hybridization, we investigated the expression patterns of collagenases-1 and -3, stromelysin-2, matrilysin, metalloelastase and TIMPs-1 and -3 in BE, <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph-node metastases</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Matrilysin was expressed abundantly in 12/15 tumours and in 4/6 lymph-node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> and its expression correlated with the histological <z:hpo ids='HP_0000718'>aggressiveness</z:hpo> of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Matrilysin and metalloelastase were upregulated already in BE </plain></SENT>
<SENT sid="6" pm="."><plain>Stromelysin-2 and collagenase-3 expression was detected only in a few <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Collagenase-1 was expressed by <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and stromal cells in 9/15 tumours </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumour</z:e>-infiltrating macrophages expressed metalloelastase in 13/15 cancers </plain></SENT>
<SENT sid="9" pm="."><plain>TIMPs-1 and -3 were expressed in 12/15 and 11/15 tumours, respectively </plain></SENT>
<SENT sid="10" pm="."><plain>Laminin-5 and tenascin were abundantly expressed at the invasive front of poorly differentiated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, but not in BE </plain></SENT>
<SENT sid="11" pm="."><plain>Our results indicate that matrilysin is the principal MMP expressed by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells in oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, and further studies are needed to investigate whether matrilysin or tenascin-C could be used as a predictive marker for progression of BE to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>